Mycobacterium tuberculosis in the extracellular compartment: An underestimated adversary

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 3, 2003, Pages 833-836

  Grosset, Jacques ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; LYMPHOKINE; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

BACTERIAL GROWTH; BACTERIAL TRANSMISSION; CELLULAR IMMUNITY; COMBINATION CHEMOTHERAPY; DELAYED HYPERSENSITIVITY; DISEASE COURSE; EXTRACELLULAR SPACE; HUMAN; IMMUNITY; LUNG ALVEOLUS MACROPHAGE; LUNG CAVITY; LUNG TUBERCULOSIS; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NOTE; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALS; ANTITUBERCULAR AGENTS; EXTRACELLULAR SPACE; HUMANS; IMMUNITY, CELLULAR; LUNG; MACROPHAGES, ALVEOLAR; MYCOBACTERIUM TUBERCULOSIS; NECROSIS; PULMONARY ALVEOLI; TUBERCULOSIS, PULMONARY;

EID: 0037417012     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.3.833-836.2003     Document Type: Note

References (38)

1. Canetti, G. 1955. The tubercle bacillus in the pulmonary lesion of man. Springer Publishing Co., Inc., New York, N.Y.
2. Chan, J., and S. H. E. Kaufmann. 1994. Immune mechanisms of protection, p. 389-415. In B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection, and control. American Society for Microbiology, Washington, D.C.
3. Cohn, D. L., and W. M. El-Sadr. 2000. Treatment of tuberculosis infection, p. 471-502. In L. B. Reichman and E. S. Hershfield (ed.), Tuberculosis, a comprehensive international approach, 2nd ed. Marcel Dekker, Inc., New York, N.Y.
4. Comstock, G. W. 2000. Epidemiology of tuberculosis, p. 129-156. In L. B. Reichman and E. S. Hershfield (ed.), Tuberculosis, a comprehensive international approach, 2nd ed. Marcel Dekker, Inc., New York, N.Y.
5. Daniel, T. M., W. H. Boom, and J. J. Ellner. 2000. Immunology of tuberculosis, p. 187-214. In L. B. Reichman and E. S. Hershfield (ed.), Tuberculosis, a comprehensive international approach, 2nd ed. Marcel Dekker, Inc., New York, N.Y.
6. Dannenberg. A. 1994. Rabbit model of tuberculosis, p. 149-156. In B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection, and control. American Society for Microbiology, Washington, D.C.
7. Dannenberg, A. M., and G. A. W. Rook. 1994. Pathogenesis of pulmonary tuberculosis: an interplay of tissue-damaging and macrophage-activating immune responses, dual mechanisms that control bacillary multiplication, p. 459-483. In B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection, and control. American Society for Microbiology, Washington, D.C.
8. Enarson, D. A., and A. Rouillon. 1994. The epidemiological basis of tuberculosis control, p. 19-32. In P. D. O. Davis (ed.), Clinical tuberculosis. Chapman & Hall, London, United Kingdom.
9. Flynn, J. L., and J. Chan. 2001. Tuberculosis: latency and reactivation. Infect. Immun. 69:4195-4201.
10. Grosset J. 1980. Bacteriologic basis of short-course chemotherapy for tuberculosis. Clin. Chest Med. 1:231-241.
11. Grzybowski, S., G. D. Barnett, and K. Styblo. 1975. Contacts of cases of active pulmonary tuberculosis. Bull. Int. Union Tuberc. Lung Dis. 50:90-106.
12. Hopewell, P. C., and R. E. Chaisson. 2000. Tuberculosis and human immunodeficiency virus infection, p. 525-552. In L. B. Reichman and E. S. Hershfield (ed.), Tuberculosis, a comprehensive international approach, 2nd ed. Marcel Dekker, Inc., New York, N.Y.
13. International Union against Tuberculosis Committee on Prophylaxis. 1982. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bull. W. H. O. 60:555-564.
14. Koch, R. 1882. Die Åtiologie der Tuberkulose. Berl. Klin. Wochenschr. 19:221-230.
15. Long, E. R. 1935. From pathology to epidemiology in tuberculosis: softening of the caseous tubercle and its results. JAMA 104:1883-1888.
16. Loudon, R. G., L. R. Bumbarna, J. Lacy, and G. K. Coffman. 1969. Aerial transmission of mycobacteria. Am. Rev. Respir. Dis. 100:165-171.
17. Lucas, S., and A. M. Nelson. 1994. Pathogenesis of tuberculosis in human immunodeficiency virus-infected people, p. 503-513. In B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection, and control. American Society for Microbiology, Washington, D.C.
18. Lurie, M. B. 1964. Resistance to tuberculosis: experimental studies in native and acquired defensive mechanisms. Harvard University Press, Cambridge, Mass.
19. McDonough, K. A., Y. Kress, and B. R. Bloom. 1993. Pathogenesis of tuberculosis: interaction of Mycobacterium tuberculosis with macrophages. Infect. Immun. 61:2763-2773.
20. McMurray, D. N. 1994. Guinea pig model of tuberculosis, p. 135-147. In B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection, and control. American Society for Microbiology, Washington, D.C.
21. Menzies, R. I. 2000. Tuberculin skin testing, p. 279-322. In L. B. Reichman and E. S. Hershfield (ed.), Tuberculosis, a comprehensive international approach, 2nd ed. Marcel Dekker, Inc., New York, N.Y.
22. Mitchison, D. A. 1998. Basic concepts in the chemotherapy of tuberculosis, p. 15-50. In P. R. J. Gangadharam and P. A. Jenkins (ed.), Mycobacteria II. Chemotherapy. Chapman & Hall, New York, N.Y.
23. Nardell, E. A., and W. F. Piessens. 2000. Transmission of tuberculosis, p. 215-240. In L. B. Reichman and E. S. Hershfield (ed.), Tuberculosis, a comprehensive international approach, 2nd ed. Marcel Dekker, Inc., New York, N.Y.
24. O'Grady, F., and R. L. Riley. 1963. Experimental airborne tuberculosis. Adv. Tuberc. Res, 12:150-190.
25. Opie, E. L., and J. D. Aronson. 1927. Tubercle bacilli in latent tuberculous lesions and in lung tissue without tuberculosis lesions. Arch. Pathol. Lab. Med. 4:1-21.
26. Orme, I. M., and F. M. Collins. 1994. Mouse model of tuberculosis, p. 113-134. In B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection, and control. American Society for Microbiology, Washington, D.C.
27. Piessens, W. F., and E. A. Nardell. 2000. Pathogenesis of tuberculosis, p. 241-260. In L. B. Reichman and E. S. Hershfield (ed.), Tuberculosis, a comprehensive international approach, 2nd ed. Marcel Dekker, Inc., New York, N.Y.
28. Rich, A. R. 1951. The pathogenesis of tuberculosis, 2nd ed. Charles C Thomas, Publisher, Springfield, Ill.
29. Riley, R. L. 1974. Airborne infection. Am. J. Med. 57:466-475.
30. Riley, R. L., C. C. Mills, F. O'Grady, L. U. Sultan, F. Wittstadt, and D. N. Shivpuri. 1962. Infectiousness of air from a tuberculous ward. Ultraviolet irradiation of infected air: comparative infectiousness of different patients. Am. Rev. Respir. Dis. 85:511-525.
31. Rook, G. A. W., and B. R. Bloom. 1994. Mechanisms of pathogenesis in tuberculosis, p. 485-501. In B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection, and control. American Society for Microbiology, Washington, D.C.
32. Shaw, J. B., and N. Wynn-Williams. 1954. Infectivity of pulmonary tuberculosis in relation to sputum status. Am. Rev. Tuberc. 69:724-732.
33. Styblo, K., J. Meijer, and I. Sutherland. 1969. The transmission of tubercle bacilli. Its trend in a human population. Tuberculosis Surveillance Research Unit report no. 1. Bull. Union Int. Tuberc. 42:5-104.
34. Sutherland, I. 1976. Recent studies in the epidemiology of tuberculosis, based on the risk of being infected with tubercle bacilli. Adv. Tuberc. Res. 19:1-63.
35. Thoen, C. O. 1994. Tuberculosis in wild and domestic mammals, p. 157-162. In B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection, and control. American Society for Microbiology, Washington, D.C.
36. Van Geuns, H. A., J. Meijer, and K. Styblo. 1975. Résultats de l'examen des sujets en contact avec des malades tuberculeux à Rotterdam en 1967-1969. Bull. Union Int. Tuberc. 50:105-119.
37. Wells, W. 1934. On air-borne infection. II. Droplets and droplet nuclei. Am. J. Hyg. 20:611-618.
38. Yamamura, Y. 1958. The pathogenesis of tuberculosis cavities. Adv. Tuberc. Res. 9:13-37.